|
gptkbp:instance_of
|
gptkb:healthcare_organization
|
|
gptkbp:bfsLayer
|
4
|
|
gptkbp:bfsParent
|
gptkb:serum_therapy_for_diphtheria
|
|
gptkbp:associated_with
|
gptkb:Koplik_spots
bull neck appearance
pseudomembrane formation
|
|
gptkbp:caused_by
|
gptkb:Corynebacterium_diphtheriae
|
|
gptkbp:complications
|
gptkb:healthcare_organization
neuropathy
myocarditis
|
|
gptkbp:distribution
|
worldwide
|
|
gptkbp:duration
|
2 to 3 weeks
|
|
gptkbp:end_of_life
|
5 to 10 percent
up to 20 percent in severe cases
|
|
gptkbp:first_described_by
|
gptkb:Hippocrates
gptkb:Galen
|
|
gptkbp:healthcare
|
antibiotic resistance
vaccine hesitancy
|
|
gptkbp:historical_analysis
|
gptkb:hospital
mercury
bloodletting
|
|
gptkbp:historical_significance
|
epidemics in the 19th century
decline due to vaccination
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
diphtheria
|
|
gptkbp:incubation_period
|
2 to 5 days
|
|
gptkbp:is_protected_by
|
vaccination
|
|
gptkbp:is_vulnerable_to
|
gptkb:Tdap_vaccine
DTP vaccine
D Ta P vaccine
DTP at 2, 4, 6 months
booster at 15-18 months
booster every 10 years
over 90 percent
|
|
gptkbp:notable_event
|
gptkb:Ludwig_van_Beethoven
gptkb:George_Washington
gptkb:Fanny_Brice
gptkb:Henry_Ford
gptkb:John_Adams
|
|
gptkbp:risk_factor
|
elderly individuals
young children
immunocompromised individuals
unvaccinated individuals
|
|
gptkbp:social_responsibility
|
PCR test
common in developing countries
throat culture
rare in developed countries
|
|
gptkbp:symptoms
|
fever
sore throat
difficulty breathing
swollen glands
|
|
gptkbp:transmission
|
person-to-person contact
|
|
gptkbp:treatment
|
antibiotics
antitoxin
|